Chemed (CHE) Revenue (2009 - 2026)

Chemed has reported Revenue for 18 years, with the latest figure at $657.5 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 1.63% year-over-year to $657.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 billion (up 2.07% YoY), and the FY2025 full-year result was $2.5 billion, up 4.06% from the prior year.
• Revenue for Q1 2026 stood at $657.5 million, up from $639.3 million in the prior quarter.
• The five-year high for Revenue was $657.5 million in Q1 2026, with the low at $526.5 million in Q3 2022.
• Average Revenue over 5 years is $589.3 million, with a median of $589.2 million recorded in 2024.
• Year-over-year, Revenue dropped 2.26% in 2022 and climbed 9.79% in 2025.
• Tracing CHE's Revenue over 5 years: stood at $546.7 million in 2022, then grew by 7.18% to $585.9 million in 2023, then rose by 9.23% to $640.0 million in 2024, then fell by 0.1% to $639.3 million in 2025, then gained by 2.84% to $657.5 million in 2026.
• The last three Revenue figures came in at $657.5 million (Q1 2026), $639.3 million (Q4 2025), and $624.9 million (Q3 2025), per Business Quant data.

Peer Comparison